D.E. Shaw & Co’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

D.E. Shaw & Co’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-113,848	Closed	-$665K	–	3818
2022 Q4	$665K	Buy	+113,848	New	+$665K	﹤0.01%	2608
2022 Q3	–	Sell	-25,901	Closed	-$109K	–	4337
2022 Q2	$109K	Sell	25,901 -6,646	-20%	-$28K	﹤0.01%	3537
2022 Q1	$110K	Sell	32,547 -12,772	-28%	-$43.2K	﹤0.01%	3736
2021 Q4	$143K	Buy	45,319 +18,296	+68%	+$57.7K	﹤0.01%	3581
2021 Q3	$88K	Sell	27,023 -4,704	-15%	-$15.3K	﹤0.01%	3413
2021 Q2	$134K	Sell	31,727 -37,102	-54%	-$157K	﹤0.01%	3303
2021 Q1	$344K	Buy	68,829 +10,756	+19%	+$53.8K	﹤0.01%	2616
2020 Q4	$734K	Buy	58,073 +2,004	+4%	+$25.3K	﹤0.01%	2155
2020 Q3	$551K	Buy	56,069 +23,478	+72%	+$231K	﹤0.01%	2084
2020 Q2	$324K	Buy	32,591 +4,659	+17%	+$46.3K	﹤0.01%	2312
2020 Q1	$247K	Sell	27,932 -12,499	-31%	-$111K	﹤0.01%	2391
2019 Q4	$373K	Buy	40,431 +354	+0.9%	+$3.27K	﹤0.01%	2295
2019 Q3	$236K	Sell	40,077 -10,892	-21%	-$64.1K	﹤0.01%	2354
2019 Q2	$612K	Buy	50,969 +7,812	+18%	+$93.8K	﹤0.01%	2069
2019 Q1	$521K	Sell	43,157 -915	-2%	-$11K	﹤0.01%	2108
2018 Q4	$553K	Sell	44,072 -22,569	-34%	-$283K	﹤0.01%	2072
2018 Q3	$989K	Buy	66,641 +7,578	+13%	+$112K	﹤0.01%	1834
2018 Q2	$994K	Buy	59,063 +12,196	+26%	+$205K	﹤0.01%	1902
2018 Q1	$1.07M	Sell	46,867 -56,550	-55%	-$1.29M	﹤0.01%	1780
2017 Q4	$2.68M	Sell	103,417 -198,419	-66%	-$5.13M	﹤0.01%	1363
2017 Q3	$4.45M	Sell	301,836 -13,893	-4%	-$205K	0.01%	1074
2017 Q2	$4.4M	Buy	315,729 +22,426	+8%	+$313K	0.01%	1076
2017 Q1	$5M	Buy	293,303 +235,015	+403%	+$4.01M	0.01%	984
2016 Q4	$600K	Buy	58,288 +17,785	+44%	+$183K	﹤0.01%	1954
2016 Q3	$409K	Buy	40,503 +15,692	+63%	+$158K	﹤0.01%	2078
2016 Q2	$279K	Buy	+24,811	New	+$279K	﹤0.01%	2277